These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 12903495)
1. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods]. Wang X; Zhang J; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder. Shrestha ML; Miyake H; Kikutsuji T; Tashiro S J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969 [TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677 [TBL] [Abstract][Full Text] [Related]
4. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma. Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566 [TBL] [Abstract][Full Text] [Related]
8. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921 [TBL] [Abstract][Full Text] [Related]
11. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions. Harada K; Zen Y; Kanemori Y; Chen TC; Chen MF; Yeh TS; Jan YY; Masuda S; Nimura Y; Takasawa S; Okamoto H; Nakanuma Y Hepatology; 2001 May; 33(5):1036-42. PubMed ID: 11343228 [TBL] [Abstract][Full Text] [Related]
12. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934 [TBL] [Abstract][Full Text] [Related]
13. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance. Zheng J; Zhu YM Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040 [TBL] [Abstract][Full Text] [Related]
14. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624 [TBL] [Abstract][Full Text] [Related]
15. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431 [TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma. Chen RF; Li ZH; Zou SQ; Chen JS Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924 [TBL] [Abstract][Full Text] [Related]
17. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Su MC; Hsu C; Kao HL; Jeng YM Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303 [TBL] [Abstract][Full Text] [Related]
18. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907 [TBL] [Abstract][Full Text] [Related]
19. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas]. Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285 [TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]